ABSTRACT
Background This study aimed to discover which young adults vape, the reasons given for vaping, and which reasons for vaping are associated with continued vaping/smoking.
Methods In a UK cohort of 3,994 young adults, we explored the association of retrospectively-recalled reasons for vaping by 23 years with vaping/smoking status at 24 years. Using logistic regression, we assessed the association with vaping behaviour among ever vapers who had ever smoked (n=668), and with smoking behaviour among individuals who regularly smoked prior to vaping (n=412).
Results Vaping to quit smoking was associated with higher likelihood of vaping (odds ratio [OR] = 3.51, 95% confidence interval [95%CI] = 2.29 to 5.38), but lower likelihood of smoking at 24 years (OR = 0.50, 95%CI = 0.32 to 0.78). Vaping to cut down smoking was associated with higher likelihood of vaping (OR = 2.90, 95%CI = 1.87 to 4.50) and smoking at 24 years (OR = 1.62, 95%CI = 1.02 to 2.58). Vaping out of curiosity was associated with lower likelihood of vaping at 24 years (OR = 0.41, 95%CI = 0.26 to 0.63) but higher likelihood of smoking at 24 years (OR = 1.66, 95%CI = 1.04 to 2.65).
Conclusions Intention to quit smoking appears important for young adults to stop smoking using e-cigarettes; vaping to cut down is associated with continued smoking, but smoking to quit is associated with discontinued smoking. Vaping out of curiosity is less likely to lead to a change in smoking/vaping behaviour (i.e., current smokers continue to smoke).
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This publication is the work of the authors and JK, AT and MM will serve as guarantors for the contents of this paper. J.K and M.M are members of the UK Centre for Tobacco and Alcohol Studies, a UKCRC Public Health Research: Centre of Excellence. Funding from British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and the National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. This work was supported by the Medical Research Centre Integrative Epidemiology Unit at the University of Bristol [grant number MC_UU_0011/7]. The UK Medical Research Council and Wellcome (Grant ref: 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). This work was also supported by CRUK (grant numbers C18281/A19169 and C57854/A22171), Wellcome Trust and the UK Medical Research Council (grant number: 092731).
Author Declarations
All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.
Not Applicable
Data Availability
The ALSPAC study website contains details of all the data that is available through a fully searchable data dictionary and variable search tool (http://www.bristol.ac.uk/alspac/researchers/our-data/). Data access is restricted but can be requested (http://www.bristol.ac.uk/alspac/researchers/access/).
